Atreca, Inc. Financing cash flow

Financing cash flow of BCEL for past 10 years: annual, quarterly and twelve month trailing (TTM) including Financing cash flow growth rates and interactive chart.


Highlights and Quick Summary

  • Financing cash flow for the quarter ending September 30, 2022 was $145 Thousand (a -1711.11% decrease compared to previous quarter)
  • Year-over-year quarterly Financing cash flow decreased by -96.68%
  • Annual Financing cash flow for 2021 was $5.45 Million (a -95.77% decrease from previous year)
  • Annual Financing cash flow for 2020 was $129 Million (a -1.76% decrease from previous year)
  • Annual Financing cash flow for 2019 was $131 Million (a 9.04% increase from previous year)
  • Twelve month Financing cash flow ending September 30, 2022 was $8.28 Million (a -2.31% decrease compared to previous quarter)
  • Twelve month trailing Financing cash flow increased by 51.96% year-over-year
Trailing Financing cash flow for the last four month:
30 Sep '22 30 Jun '22 31 Mar '22 31 Dec '21
$8.28 Million $8.47 Million $8.5 Million $5.45 Million
Visit stockrow.com/BCEL for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical Financing cash flow of Atreca, Inc.

Most recent Financing cash flowof BCEL including historical data for past 10 years.

Interactive Chart of Financing cash flow of Atreca, Inc.

Atreca, Inc. Financing cash flow for the past 10 Years (both Annual and Quarterly)

(All values are in $ million)

Year Q1 Q2 Q3 Q4 Fiscal Year
2022 $0.15 $-0.01 $3.77
2021 $4.37 $0.34 $0.02 $0.71 $5.45
2020 $0.44 $126.96 $0.53 $0.94 $128.87
2019 $0.04 $-2.13 $133.32 $-0.06 $131.17
2018 $0.0 $120.32 $-0.01 $120.3
2017 $34.29

Business Profile of Atreca, Inc.

Sector: Healthcare
Industry: Biotechnology